Scientists launch national effort to unlock liver cancer secrets
NCT ID NCT04145141
First seen Nov 01, 2025 · Last updated Jun 18, 2026 · Updated 36 times
Summary
This study aims to better understand primary liver cancer by collecting blood, urine, stool, and tissue samples from 132 adults who have had or plan to have immunotherapy. Researchers will analyze these samples to learn how the disease develops and progresses. Participants do not receive any treatment as part of this study and are followed for life via phone or email check-ins every 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.